ArticleInternational journal of preventive medicine2026
Which One Can Detect More Osteopenia and Osteoporosis in Rheumatoid Arthritis Patient? Dual-Energy X-Ray Absorptiometry (DXA) or Trabecular Bone Score (TBS).
Article in International journal of preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The early diagnosis of osteopenia and osteoporosis can slow the progression of osteoporosis and postpone possible bone fractures in patients with rheumatoid arthritis (RA) because of the benefit of timely treatments. This study was conducted to evaluate the efficiency of dual-energy X-ray absorptiometry (DXA) and trabecular bone score (TBS) in patients with RA to introduce a better method for the early diagnosis of osteopenia and osteoporosis. Methods: Data on DXA and TBS from 88 patients with RA and 52 healthy people who met the inclusion criteria of this retrospective study were analyzed based on descriptive and inferential statistics. Results: A significant difference was observed between the diagnostic abilities of TBS and DXA. Unlike the TBS method, DXA detected higher percentages of RA patients with osteopenia (31.82% TBS vs. 51.14% DXA) and osteoporosis (21.59% TBS vs. 26.14% DXA). Gender might also affect the diagnostic ability of DXA and TBS in patients with RA. In a group of RA patients, TBS diagnosed a lower percentage of patients with osteopenia and osteoporosis (26.83% TBS vs. 68.29% DXA for osteopenia and 17.07% TBS vs. 26.82% DXA for osteoporosis). These results may indicate a lower accuracy of the TBS method for diagnosing bone mass than DXA. Conclusions: Although previous studies have demonstrated that TBS is a proper method for the evaluation of bone microstructure, our study suggests that the results of the DXA should not be ignored for the early detection of osteopenia and osteoporosis in patients with RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.